Russian Sputnik V Phase 1 And 2 Trials Results Published

The preliminary results of the phase 1 and 2 trials of Russia's Sputnik V COVID-19 vaccine have been published in The Lancet. Researchers found that the vaccine produced anti-bodies in all 72 participants within 21 days and has a good safety profile. It was on the basis of these initial results that Russia announced their vaccine as safe for use on August 11.